| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mai―30 |
Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort |
Joep Schellens, Magdolna Nagy, Anne-Marije Hulshof, Frank van Rosmalen, René van Oerle, Thijs T.W. van Herpt, Teba Alnima, Mark M.G. Mulder, Dave Hellenbrand, Hugo ten Cate, Rob G.H. Driessen, Jan-Willem E.M. Sels, Iwan C.C. van der Horst, Yvonne M.C. Henskens, Bas C.T. van Bussel, Henri M.H. Spronk |
| 2 |
[GO] |
2026―Mai―25 |
Prolonged D-dimer elevation after COVID-19: diagnostic noise or residual risk in suspected pulmonary embolism? |
Nikola Milovanovic, Aleksandra Zivanic, Ivona Vranic Jovanovic, Sofija Aleksandra Neskovic, Katarina Grujicic, Nenad Janeski, Ivan Stankovic |
| 3 |
[GO] |
2026―Apr―10 |
Acute pulmonary embolism incidence and mortality during the COVID-19 pandemic: A national inpatient sample analysis 2017-2022 |
Arihant Surana, Riya Bhattacharya, Edwin Saji, Jason Jacob, Arghyadeep Ganguly, Akshat Banga |
| 4 |
[GO] |
2026―Feb―18 |
Traditional and whole blood coagulative profiles across different variants of COVID-19 acute pneumonia admitted to the Internal Medicine Ward |
Luca Spiezia, Simone Guglielmo, Maria Pia Pennino, Chiara Ceolin, Margherita Vergadoro, Angela Napolitano, Chiara Simion, Elena Campello, Giuseppe Sergi, Paolo Simioni |
| 5 |
[GO] |
2025―Nov―26 |
Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned |
Miika Koskinen, Eeva Ruotsalainen, Mia Wallin, Hilkka Kivelä, Kerstin Carlsson, Jari Petäjä, Eero Hirvensalo, Markku Mäkijärvi, Riitta Lassila |
| 6 |
[GO] |
2025―Nov―20 |
Haemostatic changes following ECMO circuit replacement in adult patients with COVID-19: An exploratory retrospective study |
Bernhard Nagler, Sabrina Thurner, Peter Schellongowski, Oliver Robak, Alexander Hermann, Thomas Staudinger, Nina Buchtele |
| 7 |
[GO] |
2025―Sep―30 |
Reduced ADP-induced platelet aggregation may predict poor clinical outcomes in patients with COVID-19 |
Hiroyuki Koami, Yuichiro Sakamoto, Yutaro Furukawa, Ayaka Matsuoka, Kota Shinada, Kento Nakayama, Ryota Sakurai, Sachiko Iwanaga, Takayuki Onohara, Mayuko Koba |
| 8 |
[GO] |
2025―Sep―22 |
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials |
Luis Ortega-Paz, Azita H. Talasaz, Parham Sadeghipour, Sina Rashedi, Jean M. Connors, Dominick J. Angiolillo, Larisa H. Cavallari, David Jimenez, Gabriela Bastidas, Elizabeth Lorenzi, Lindsay R. Berry, Thomas Hills, Daniel Francis McAuley, Tayyab Shah, Alexandra J. Lansky, Siddharthan Deepti, Hernando Guillermo Gaitán-Duarte, Tatjana S. Potpara, Mattia Galli, Dave L. Dixon, Gregory Piazza, Gregory Y.H. Lip, Roxana Mehran, Peter Libby, Harlan M. Krumholz, Behnood Bikdeli |
| 9 |
[GO] |
2025―Jan―08 |
Pre-infection anticoagulant exposure and SARS-CoV-2 infection outcomes - Differential mortality by age |
Itshak Amsalem, Asher Shafrir, Yosef Kalish, Ora Paltiel |
| 10 |
[GO] |
2024―Dez―17 |
Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study |
Yishan Li, Linfeng Xi, Dingyi Wang, Guohui Fan, Xincheng Li, Yiwei Shi, Hong Chen, Chaosheng Deng, Hong Chen, Qin Luo, Zhe Cheng, Shuai Zhang, Zhu Zhang, Yunxia Zhang, Qian Gao, Qiang Huang, Wanmu Xie, Zhenguo Zhai, Chen Wang |
| 11 |
[GO] |
2024―Nov―19 |
Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: A population-wide cohort in 2.6 million people in Wales |
Spencer Keene, Hoda Abbasizanjani, Fatemeh Torabi, Rochelle Knight, Venexia Walker, Elena Raffetti, Genevieve Cezard, Samantha Ip, Alexia Sampri, Thomas Bolton, Rachel Denholm, Kamlesh Khunti, Ashley Akbari, Jennifer Quint, Spiros Denaxas, Cathie Sudlow, Emanuele Di Angelantonio, Jonathan A.C. Sterne, Angela Wood, William N. Whiteley |
| 12 |
[GO] |
2024―Okt―18 |
Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice |
Renat Roytenberg, Hong Yue, Autumn DeHart, Eugene Kim, Fang Bai, Yongick Kim, Krista Denning, Alec Kwei, Quan Zhang, Jiang Liu, X. Long Zheng, Wei Li |
| 13 |
[GO] |
2024―Okt―03 |
Elevated levels of pro-thrombotic eNOS-negative platelets in COVID-19 patients |
Amir Asgari, Aleksandra Franczak, Alex Herchen, Glen C. Jickling, Paul Jurasz |
| 14 |
[GO] |
2024―Sep―23 |
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics |
Sara McElroy, Emily Cramer, Lauren Amos |
| 15 |
[GO] |
2024―Aug―30 |
Tocilizumab reduces hypercoagulation in COVID-19 - Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial |
Lou M. Almskog, Anna Sjöström, Jonas Sundén-Cullberg, Apostolos Taxiarchis, Anna Ågren, Sara Freyland, Madeleine Börjesson, Agneta Wikman, Carl Magnus Wahlgren, Michael Wanecek, Jan van der Linden, Jovan Antovic, Jon Lampa, Maria Magnusson |
| 16 |
[GO] |
2024―Jul―05 |
Analysis of real-world data pulmonary embolism as the underlying cause of death during the COVID-19 pandemic |
Giuseppe Lippi, Camilla Mattiuzzi |
| 17 |
[GO] |
2024―Mai―07 |
Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis |
Jude Mary Cénat, Elisabeth Dromer, Seyed Mohammad Mahdi Moshirian Farahi, Christa Masengesho Ndamage, Aiden Yun, Hannah Zuta, Jihane Mkhatri, Eden Samson, Raina Barara, Patrick R. Labelle, Yan Xu |
| 18 |
[GO] |
2024―Mai―01 |
Downregulation of protein S in patients with severe COVID-19 augments the prothrombotic state |
Devin Melancon, Tina Nguyen, Verima Pereira, Jarrod Harman, Sabyasachi Chatterjee, Arnold H. Zea, Samarpan Majumder, Rinku Majumder |
| 19 |
[GO] |
2024―Mai―01 |
Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis |
Stefanie Reis, Amon Faske, Ina Monsef, Florian Langer, Oliver J. Müller, Peter Kranke, Patrick Meybohm, Stephanie Weibel |
| 20 |
[GO] |
2024―Apr―29 |
The course of pulmonary embolism in individuals recovered from COVID-19 |
Coşkun Doğan, Samet Samanci |
| 21 |
[GO] |
2024―Apr―06 |
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19 |
Behnood Bikdeli, Darsiya Krishnathasan, Candrika D. Khairani, Antoine Bejjani, Julia Davies, Nicole Porio, Anthony Tristani, Andre Armero, Ali A. Assi, Victor Nauffal, Umberto Campia, Zaid Almarzooq, Eric Wei, Marcos D. Ortiz-Rios, Valeria Zuluaga-Sánchez, Aditya Achanta, Sirus J. Jesudasen, Bruce Tiu, Geno J. Merli, Orly Leiva, John Fanikos, Elvira Grandone, Aditya Sharma, Samantha Rizzo, Mariana B. Pfeferman, Ruth B. Morrison, Alec Vishnevsky, Judith Hsia, Mark R. Nehler, James Welker, Marc P. Bonaca, Brett Carroll, Samuel Z. Goldhaber, Zhou Lan, Gregory Piazza |
| 22 |
[GO] |
2024―Jan―12 |
COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds |
Damon E. Houghton, Ana I. Casanegra, Waldemar E. Wysokinski, Leslie J. Padrnos, Ewa Wysokinska, Rajiv Pruthi, Heather Heaton, Meera Sridharan, Robert D. McBane, Surbhi Shah |
| 23 |
[GO] |
2023―Dez―21 |
Whole blood viscoelastic testing profile and mortality in patients hospitalized with acute COVID-19 pneumonia: A systematic review and meta-analysis |
Luca Spiezia, Elena Campello, Paolo Simioni, Mario I. Lumbreras-Marquez |
| 24 |
[GO] |
2023―Sep―16 |
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study |
Daphne J. Theodorou, Stavroula J. Theodorou, Dimitrios Rizos |
| 25 |
[GO] |
2023―Aug―18 |
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials |
Stefano Barco, Saverio Virdone, Andrea Götschi, Walter Ageno, Juan I. Arcelus, Roland Bingisser, Giuseppe Colucci, Frank Cools, Daniel Duerschmied, Harry Gibbs, Riccardo M. Fumagalli, Bernhard Gerber, Sylvia Haas, Jelle C.L. Himmelreich, Richard Hobbs, Lukas Hobohm, Barry Jacobson, Gloria Kayani, Renato D. Lopes, Peter MacCallum, Evy Micieli, Marc Righini, Helia Robert-Ebadi, Ana Thereza Rocha, Thomas Rosemann, Jitendra Sawhney, Sebastian Schellong, Tim Sebastian, David Spirk, Stefan Stortecky, Alexander G.G. Turpie, Davide Voci, Nils Kucher, Karen Pieper, Ulrike Held, Ajay K. Kakkar |
| 26 |
[GO] |
2023―Jul―19 |
Thrombocytopenia is associated with a dysregulated host response in severe COVID-19 |
Brent Appelman, Erik H.A. Michels, Justin de Brabander, Hessel Peters-Sengers, Rombout B.E. van Amstel, Sophie M. Noordzij, Augustijn M. Klarenbeek, Christine C.A. van Linge, Osoul Chouchane, Alex R. Schuurman, Tom D.Y. Reijnders, Renée A. Douma, Lieuwe D.J. Bos, W. Joost Wiersinga, Tom van der Poll |
| 27 |
[GO] |
2023―Jun―28 |
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 28 |
[GO] |
2023―Jun―24 |
Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes |
Lucia Filippi, Gianni Turcato, Marta Milan, Sofia Barbar, Eliana Miozzo, Arian Zaboli, Diego Tonello, Daniela Milazzo, Massimo Marchetti, Stefano Cuppini, Paolo Prandoni |
| 29 |
[GO] |
2023―Jun―15 |
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination |
I. Ivanko, I. Ćelap, S. Margetić, D. Marijančević, J. Josipović, P. Gaćina |
| 30 |
[GO] |
2023―Jun―12 |
The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists |
Chantal Visser, Arjen Yousefi, Melchior C. Nierman, Menno V. Huisman, Anouk J.W. Gulpen, C. Heleen van Ommen, Marieke J.H.A. Kruip |
| 31 |
[GO] |
2023―Mai―30 |
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study |
Behnood Bikdeli, Candrika D. Khairani, Darsiya Krishnathasan, Antoine Bejjani, Andre Armero, Anthony Tristani, Julia Davies, Nicole Porio, Ali A. Assi, Victor Nauffal, Umberto Campia, Zaid Almarzooq, Eric Wei, Aditya Achanta, Sirus J. Jesudasen, Bruce C. Tiu, Geno J. Merli, Orly Leiva, John Fanikos, Aditya Sharma, Alec Vishnewsky, Judith Hsia, Mark R. Nehler, James Welker, Marc P. Bonaca, Brett J. Carroll, Zhou Lan, Samuel Z. Goldhaber, Gregory Piazza |
| 32 |
[GO] |
2023―Mai―20 |
Alterations in the megakaryocyte transcriptome impacts platelet function in sepsis and COVID-19 infection |
Abigail Ajanel, Elizabeth A. Middleton |
| 33 |
[GO] |
2023―Mrz―23 |
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies |
Sonia Elhadad, David Redmond, Adrian Tan, Jenny Huang, Beatriz Lorenzo Rodriguez, Sabrina E. Racine-Brzostek, Sandeep Subrahmanian, Jasimuddin Ahamed, Jeffrey Laurence |
| 34 |
[GO] |
2023―Feb―10 |
Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial |
Olivier Pantet, Christophe Combescure, Zied Ltaief, Lucia Mazzolai, Séverin Jeanneret, Sara Manzocchi-Besson, Hans Stricker, Sara Cereghetti, Jérôme Pugin, Alexandra Calmy, Christophe Marti, Helia Robert-Ebadi, Pierre Fontana, Marc Righini, Alessandro Casini, Marc Blondon |
| 35 |
[GO] |
2023―Feb―03 |
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 36 |
[GO] |
2023―Feb―02 |
SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply |
Massimo Franchini, Daniele Focosi |
| 37 |
[GO] |
2023―Jan―25 |
Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients |
Krzysztof Wójcik, Stanisława Bazan-Socha, Natalia Celejewska-Wójcik, Karolina Górka, Sabina Lichołai, Kamil Polok, Tomasz Stachura, Lech Zaręba, Radosław Dziedzic, Ada Gradzikiewicz, Marek Sanak, Jacek Musiał, Krzysztof Sładek, Teresa Iwaniec |
| 38 |
[GO] |
2023―Jan―18 |
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study |
Marta Brambilla, Paola Canzano, Patrizia Della Valle, Alessia Becchetti, Maria Conti, Mariangela Alberti, Arianna Galotta, Maria Luisa Biondi, Paola Adele Lonati, Fabrizio Veglia, Alice Bonomi, Nicola Cosentino, Pier Luigi Meroni, Gian Vincenzo Zuccotti, Armando D'Angelo, Marina Camera |
| 39 |
[GO] |
2023―Jan―02 |
Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study |
Jean-Christophe Gris, Florence Guillotin, Taissa Pereira dos Santos, Mathias Chéa, Paul Loubet, Didier Laureillard, Albert Sotto, Laurent Muller, Saber Davide Barbar, Claire Roger, Jean-Yves Lefrant, Boris Jung, Kada Klouche, Thibault Mura, Isabelle Quéré, Antonia Perez-Martin |
| 40 |
[GO] |
2022―Dez―28 |
Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series study |
Muireann Walton, Robert Tomkies, Thomas Teunissen, Thomas Lumley, Timothy Hanlon |
| 41 |
[GO] |
2022―Dez―18 |
Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update |
Massimo Franchini, Daniele Focosi |
| 42 |
[GO] |
2022―Dez―01 |
Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study |
M. Hardy, I. Michaux, P. Bulpa, B. Schonau, B. Nicolay, E. de Maistre, A. Godon, T. Lecompte, F. Mullier |
| 43 |
[GO] |
2022―Nov―25 |
Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis |
Meng-Fei Dai, Wen-Xiu Xin, Sisi Kong, Hai-Ying Ding, Luo Fang |
| 44 |
[GO] |
2022―Nov―13 |
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial |
Davide Voci, Andrea Götschi, Ulrike Held, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Riccardo M. Fumagalli, Bernhard Gerber, Barbara Hasse, Dagmar I. Keller, Stavros V. Konstantinides, François Mach, Silvana K. Rampini, Marc Righini, Helia Robert-Ebadi, Thomas Rosemann, Stéphanie Roth-Zetzsche, Tim Sebastian, Noemi R. Simon, David Spirk, Stefan Stortecky, Lukas Vaisnora, Nils Kucher, Stefano Barco |
| 45 |
[GO] |
2022―Nov―08 |
Platelet dysfunction and thrombus instability in flow conditions in patients with severe COVID-19 |
Charles Tacquard, Clarisse Mouriaux, Xavier Delabranche, Catherine Bourdon, Anita Eckly, Stéphanie Magnenat, Laurent Sattler, Christian Gachet, Paul Michel Mertes, Beatrice Hechler, Pierre H. Mangin |
| 46 |
[GO] |
2022―Okt―26 |
SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients |
Kenan Toprak, Mustafa Kaplangoray, Ali Palice, Mustafa Begenç Taşcanov, Mehmet İnanır, Tolga Memioğlu, Zafer Kök, Asuman Biçer, Recep Demirbağ |
| 47 |
[GO] |
2022―Okt―22 |
The homophilic CD84 receptor is upregulated on platelets in COVID-19 and sepsis |
Lukas J. Weiss, Maria Drayss, Kristina Mott, Margret Droste, Bastian Just, Anna M. Arold, Bernhard Nieswandt, Dirk Weismann, David Stegner, Harald Schulze |
| 48 |
[GO] |
2022―Okt―11 |
Delayed catastrophic thrombotic events in post-acute COVID-19 |
Abhinav Gupta, Ashis Kumar Satapathy, Pravakar Bahinipati |
| 49 |
[GO] |
2022―Okt―06 |
Circulating immune cells with megakaryocyte signature in response to COVID-19 mRNA vaccination |
Taisuke Kanaji, Yosuke Morodomi, Sachiko Kanaji |
| 50 |
[GO] |
2022―Okt―01 |
Tissue factor in COVID-19-associated coagulopathy |
Saravanan Subramaniam, Hema Kothari, Markus Bosmann |
| 51 |
[GO] |
2022―Sep―17 |
Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19 |
Luca Quartuccio, Arianna Sonaglia, Letizia Casarotto, Dennis McGonagle, Carla Di Loreto, Enrico Pegolo |
| 52 |
[GO] |
2022―Sep―15 |
Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients |
Esther M. Speksnijder, Lisa M. Hessels, Linda Muusses, Harry R. Büller, Wim G. Boersma, Suat Simsek |
| 53 |
[GO] |
2022―Sep―08 |
Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis |
Stefanie Reis, Maria Popp, Selina Schießer, Maria-Inti Metzendorf, Peter Kranke, Patrick Meybohm, Stephanie Weibel |
| 54 |
[GO] |
2022―Aug―28 |
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors |
Minna Voigtlaender, Carolin Edler, Moritz Gerling, Julia Schädler, Benjamin Ondruschka, Ann Sophie Schröder, Jan Sperhake, Stephan Ehrhardt, Lin Wang, Munif Haddad, Verena Kiencke, Thomas Renné, Kevin Roedl, Stefan Kluge, Dominic Wichmann, Florian Langer |
| 55 |
[GO] |
2022―Aug―18 |
Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis |
Xin Xu, Yao Feng, Yitong Jia, Xiao Zhang, Long Li, Xuesong Bai, Liqun Jiao |
| 56 |
[GO] |
2022―Aug―11 |
Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers |
Wagner Angelika, Garner-Spitzer Erika, Kundi Michael, Stockinger Hannes, Pabinger Ingrid, Eichinger-Hasenauer Sabine, Quehenberger Peter, Wagner Oswald, Wiedermann Ursula, Grabmeier-Pfistershammer Katharina |
| 57 |
[GO] |
2022―Jul―26 |
The long haul COVID-19 arterial thrombosis |
Maria Pia Borrelli, Adelaide Buora, Paolo Frigatti |
| 58 |
[GO] |
2022―Jul―25 |
Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies |
J.O. Williams, J. Nash, C. Whelan, B.M. Raven, A.J. Davies, J. Evans, L. Watkeys, K. Morris, P.E. James |
| 59 |
[GO] |
2022―Jul―22 |
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data |
Sung-Hee Choi, Hang Nguyen, Shifa Kanjwal, Ibrahim Ibrahim, Taha Bat, Abey Thomas, Haekyung Jeon-Slaughter |
| 60 |
[GO] |
2022―Jul―16 |
Impact of pharmacist intervention on anticoagulation management and risk for potential COVID-19 exposure during the COVID-19 pandemic |
Lindsey C. Lee, Phillip Farwig, Lauren Kirk, Virginia D. Mitchell, Jennifer A. Sabatino, Kelli D. Barnes |
| 61 |
[GO] |
2022―Jul―05 |
Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors |
Rebecca Müller, Gabi Rink, Günalp Uzun, Tamam Bakchoul, Patrick Wuchter, Harald Klüter, Peter Bugert |
| 62 |
[GO] |
2022―Jun―25 |
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry |
Eiji Shibahashi, Kentaro Jujo, Shunsuke Kuroda, Shingo Matsumoto, Takahide Sano, Takeshi Kitai, Taishi Yonetsu, Shun Kohsaka, Sho Torii, Tetsuo Yamaguchi, Takuya Kishi, Issei Komuro, Kenichi Hirata, Koichi Node, Yuya Matsue |
| 63 |
[GO] |
2022―Mai―26 |
COVID-19 associated coagulopathy and thrombosis in cancer |
Marcel Levi, Nick van Es |
| 64 |
[GO] |
2022―Mai―18 |
Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis? |
Marijana Grgić Medić, Gordana Tomac, Vladimira Rimac, Karin Zibar Tomšić, Ivana Kraljević, Ana Boban |
| 65 |
[GO] |
2022―Mai―02 |
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases |
Prachi Saluja, Nitesh Gautam, Sisira Yadala, Anand N. Venkata |
| 66 |
[GO] |
2022―Apr―20 |
No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19 |
Angelo Porfidia, Giorgio Esposto, Chiara Manzo, Paolo Santini, Roberto Pola |
| 67 |
[GO] |
2022―Apr―18 |
Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients |
Marko Lucijanic, Ivana Jurin, Martina Sedinic, Ena Soric, Anica Sabljic, Ivan Krecak, Josko Mitrovic, Daniela Marelic, Zvonimir Kremer, Irzal Hadzibegovic, Tomo Lucijanic, Rajko Kusec |
| 68 |
[GO] |
2022―Apr―01 |
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study |
Yugo Yamashita, Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Ichizo Tsujino, Junichi Nakamura, Naoto Yamamoto, Hiroko Nakata, Satoshi Ikeda, Michihisa Umetsu, Shizu Aikawa, Hiroya Hayashi, Hirono Satokawa, Yoshinori Okuno, Eriko Iwata, Yoshito Ogihara, Nobutaka Ikeda, Akane Kondo, Takehisa Iwai, Norikazu Yamada, Tomohiro Ogawa, Takao Kobayashi, Makoto Mo |
| 69 |
[GO] |
2022―Mrz―31 |
Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis? |
Mehran Ghasemzadeh, Javad Ahmadi, Ehteramolsadat Hosseini |
| 70 |
[GO] |
2022―Mrz―24 |
Venous thromboembolism in patients hospitalised with COVID-19 in England |
Lara N. Roberts, Annakan V. Navaratnam, Roopen Arya, Tim W.R. Briggs, William K. Gray |
| 71 |
[GO] |
2022―Mrz―18 |
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex |
Niklas Boknäs, Cia Laine, Andreas Hillarp, Ankit S. Macwan, Kerstin M. Gustafsson, Tomas L. Lindahl, Margareta Holmström |
| 72 |
[GO] |
2022―Feb―23 |
COVID-19 and thrombosis: The role of hemodynamics |
Sudeep Sastry, Federica Cuomo, Jayaveera Muthusamy |
| 73 |
[GO] |
2022―Feb―20 |
Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area |
Davide Voci, Ugo Fedeli, Ioannis T. Farmakis, Lukas Hobohm, Karsten Keller, Luca Valerio, Elena Schievano, Claudio Barbiellini Amidei, Stavros V. Konstantinides, Nils Kucher, Stefano Barco |
| 74 |
[GO] |
2022―Jan―20 |
Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine |
Maria Cristina Leone, Simone Canovi, Annalisa Pilia, Annamaria Casali, Luca Depietri, Tommaso Fasano, Rossana Colla, Angelo Ghirarduzzi |
| 75 |
[GO] |
2022―Jan―15 |
Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status |
Alexey A. Martyanov, Anna E. Boldova, Maria G. Stepanyan, Olga I. An, Alexander S. Gur'ev, Darya V. Kassina, Alexey Y. Volkov, Alexandr V. Balatskiy, Andrei A. Butylin, Sergei S. Karamzin, Elena V. Filimonova, Sergei V. Tsarenko, Sergei A. Roumiantsev, Alexander G. Rumyantsev, Mikhail A. Panteleev, Fazoil I. Ataullakhanov, Anastasia N. Sveshnikova |
| 76 |
[GO] |
2021―Dez―21 |
Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model |
Iris C. Kreft, Roy R.A. Winiarczyk, Fric J. Tanis, Carmen van der Zwaan, Katharina S. Schmitz, Arie J. Hoogendijk, Rik L. de Swart, Anne Moscona, Matteo Porotto, Daniela C.F. Salvatori, Rory D. de Vries, Moniek P.M. de Maat, Maartje van den Biggelaar, Bart J.M. van Vlijmen |
| 77 |
[GO] |
2021―Dez―20 |
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
Nathan D. Nielsen, Marian A. Rollins-Raval, Jay S. Raval, Jecko Thachil |
| 78 |
[GO] |
2021―Dez―13 |
The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study |
Husam Abdel-Qadir, Peter C. Austin, Andrea Pang, Jacob A. Udell, William H. Geerts, Candace D. McNaughton, Cynthia A. Jackevicius, Jeffrey C. Kwong, Calvin Yeh, Jafn L. Cox, Douglas S. Lee, Dennis T. Ko, Clare L. Atzema |
| 79 |
[GO] |
2021―Dez―08 |
Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis |
Aída Gil-Díaz, Almudena Gil-Hernández, Ana Isabel Lozano-Jiménez, Jorge Benítez-Peña, Alicia Conde-Martel |
| 80 |
[GO] |
2021―Dez―07 |
Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination |
Takayuki Nakamura, Yosuke Morodomi, Sachiko Kanaji, Takashi Okamura, Koji Nagafuji, Taisuke Kanaji |
| 81 |
[GO] |
2021―Dez―07 |
Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis |
Marco Zuin, Matthias M. Engelen, Stefano Barco, Alex C. Spyropoulos, Thomas Vanassche, Beverley J. Hunt, Christophe Vandenbriele, Peter Verhamme, Nils Kucher, Farid Rashidi, Giovanni Zuliani, Stavros V. Konstantinides, Loris Roncon |
| 82 |
[GO] |
2021―Dez―07 |
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
Farid Rashidi, Stefano Barco, Parisa Rezaeifar, Parham Sadeghipour, Samad Ghodrati, Hooman Bakhshandeh, Seyed Ali Mousavi-Aghdas, Armin Sadeghi, Akbar Sharifi, Hamed Valizadeh, Haleh Mikaeili, Farnaz Rafiee, Zahar Navarbaf, Gita Farajian, Behnood Bikdeli, Khalil Ansarin |
| 83 |
[GO] |
2021―Dez―06 |
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia |
Yumei Liu, Zonghong Shao, Huaquan Wang |
| 84 |
[GO] |
2021―Dez―04 |
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19 |
L.H. Willems, M. Nagy, H. ten Cate, H.M.H. Spronk, L.A. Groh, J. Leentjens, N.A.F. Janssen, M.G. Netea, D.H.J. Thijssen, G. Hannink, A.S. van Petersen, M.C. Warlé |
| 85 |
[GO] |
2021―Nov―16 |
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
Marco Zuin, Carlo Cervellati, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon |
| 86 |
[GO] |
2021―Nov―06 |
COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets |
Hanna H. Pitkänen, Annukka Jouppila, Tuukka Helin, Vinaya Dulipati, Juha Kotimaa, Seppo Meri, Anu Kantele, Pinja Jalkanen, Ilkka Julkunen, Riitta Lassila |
| 87 |
[GO] |
2021―Okt―25 |
Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients |
Mireia Constans, Raquel Santiago, Lidia Jimenez, Cristina Motllo, Rosario Lopez, Jaume Trapé, J. Carlos Reverter, Albert Altes |
| 88 |
[GO] |
2021―Okt―18 |
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study |
Thijs F. van Haaps, Didier Collard, Frits H.M. van Osch, Saskia Middeldorp, Michiel Coppens, Martijn D. de Kruif, Eline A. Vlot, Renée A. Douma, Hugo ten Cate, Nicole P. Juffermans, Niels Gritters, Alexander P. Vlaar, Auke C. Reidinga, Marjolein A. Heuvelmans, Matthijs Oudkerk, Harry R. Büller, Joop P.W. van den Bergh, Arno Maas, Marije Ten Wolde, Suat Simsek, Martijn Beudel, Nick van Es |
| 89 |
[GO] |
2021―Okt―11 |
Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study |
Carmen Rodríguez, Alberto Pérez-Nieva, Luis Máiz, María del Mar Meijón, Pilar Llamas, Manuel Monreal, Behnood Bikdeli, David Jiménez |
| 90 |
[GO] |
2021―Okt―08 |
Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts |
Delphine Douillet, Jérémie Riou, Andrea Penaloza, Thomas Moumneh, Caroline Soulie, Dominique Savary, Francois Morin, Rafaël Mahieu, Pierre-Marie Roy |
| 91 |
[GO] |
2021―Okt―07 |
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19 |
Ahmed K. Pasha, Robert D. McBane, Rahul Chaudhary, Leslie J. Padrnos, Ewa Wysokinska, Rajiv Pruthi, Aneel Ashrani, Paul Daniels, Meera Sridharan, Waldemar E. Wysokinski, Damon E. Houghton |
| 92 |
[GO] |
2021―Okt―07 |
Covid-19 vaccination, adverse events, and detection of antibodies |
Søren Risom Kristensen, Jette Nybo, Annebirthe Bo Hansen, Siw Leiknes Ernstsen |
| 93 |
[GO] |
2021―Sep―24 |
Systematic screening for pulmonary embolism using the years algorithm in patients with suspected COVID-19 in the emergency department |
Inge H.Y. Luu, Féline P.B. Kroon, Jacqueline Buijs, Jasenko Krdzalic, Martijn D. de Kruif, Math P.G. Leers, Guy J.M. Mostard, Remy J.H. Martens, Remy L.M. Mostard, Daan J.L. van Twist |
| 94 |
[GO] |
2021―Sep―21 |
Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic |
Amélie Gabet, Clémence Grave, Philippe Tuppin, Joseph Emmerich, Valérie Olié |
| 95 |
[GO] |
2021―Sep―17 |
Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group |
Joel G. Ray, Theodore E. Warkentin, Alison L. Park |
| 96 |
[GO] |
2021―Aug―28 |
Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways |
Rinkoo Dalan, Bernhard O. Boehm |
| 97 |
[GO] |
2021―Aug―27 |
Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship? |
Björn Stessel, Jeroen Peeters, Liesbeth Bruckers, Marijke Nulens, Ina Callebaut, Jan Poelaert, Jasperina Dubois |
| 98 |
[GO] |
2021―Aug―26 |
Impact of blood type on thrombosis and disease severity in adult COVID-19 patients |
Shivani Rao, Surbhi Warrior, Shengyuan Luo, Sefer Gezer, Parameswaran Venugopal, Shivi Jain |
| 99 |
[GO] |
2021―Aug―25 |
Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients |
Wolmet E. Haksteen, Bashar N. Hilderink, Romein W.G. Dujardin, Rogier R. Jansen, Caspar J. Hodiamont, Pieter R. Tuinman, Jasper M. Smit, Marcella C.A. Müller, Nicole P. Juffermans |
| 100 |
[GO] |
2021―Aug―13 |
Morphological and functional alterations in endothelial colony-forming cells from recovered COVID-19 patients |
José Antonio Alvarado-Moreno, Jorge Davila-Moreno, Victor Dominguez-Reyes, Rodrigo Arreola-Diaz, Irma Isordia-Salas, Antonieta Chavez-Gonzalez, Abraham Majluf-Cruz |
| 101 |
[GO] |
2021―Aug―08 |
Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it? |
L. Filippi, M. Sartori, M. Facci, M. Trentin, A. Armani, M.L. Guadagnin, P. Prandoni |
| 102 |
[GO] |
2021―Aug―04 |
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia |
Ching-Tai Huang, Shao-Yun Hsu, Chien-Ho Wang, Wei-En Johnny Tseng, Chin-Yu Yang, Chip-Jin Ng, Theodore E. Warkentin, Ming-Huei Cheng |
| 103 |
[GO] |
2021―Jul―21 |
Pharmacokinetics of enoxaparin in COVID-19 critically ill patients |
Paul Jacques Zufferey, Annabelle Dupont, Julien Lanoiselée, Anne Bauters, Julien Poissy, Julien Goutay, Laurent Jean, Morgan Caplan, Lionel Levy, Sophie Susen, Xavier Delavenne |
| 104 |
[GO] |
2021―Jul―16 |
Thrombotic risk in children with COVID-19 infection: A systematic review of the literature |
Marco Zaffanello, Giorgio Piacentini, Luana Nosetti, Stefania Ganzarolli, Massimo Franchini |
| 105 |
[GO] |
2021―Jul―14 |
Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19 |
Floris T.M. Bosch, Matteo Candeloro, Nicola Potere, Ettore Porreca, Marcello Di Nisio, Pieter W. Kamphuisen |
| 106 |
[GO] |
2021―Jul―09 |
Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil |
Kendra Lys Calixto Machado, Suzana Tanquella da Rosa, Soraya Dobner, Ivan Schneider Boettcher, Gilberto Comaru Pasqualotto, Adelina Elisabeth Lehmkuhl Lopes, Tainá de Araújo, Lysandra Patricia Luchtenberg Bolduan, Maria Daniela Holthausen Perico Colombo, Marcelo Pitombeira de Lacerda |
| 107 |
[GO] |
2021―Jul―03 |
Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study |
Brandon Metra, Ross Summer, Sandra Elaine Brooks, Gautam George, Baskaran Sundaram |
| 108 |
[GO] |
2021―Jul―03 |
Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza |
Daniel Lachant, Dominick Roto, Stephen Rappaport, Paritosh Prasad, Neil Lachant, R. James White |
| 109 |
[GO] |
2021―Jun―27 |
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes |
José Miguel Rivera-Caravaca, Benjamin J.R. Buckley, Stephanie L. Harrison, Elnara Fazio-Eynullayeva, Paula Underhill, Francisco Marín, Gregory Y.H. Lip |
| 110 |
[GO] |
2021―Jun―25 |
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study |
Elena Campello, Chiara Simion, Cristiana Bulato, Claudia M. Radu, Sabrina Gavasso, Francesca Sartorello, Graziella Saggiorato, Patrizia Zerbinati, Mariangela Fadin, Luca Spiezia, Paolo Simioni |
| 111 |
[GO] |
2021―Jun―19 |
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: a retrospective study |
Alexandre Godon, Zoé Durand, Lydiane Agier, Thomas Lecompte, François Mullier, Raphaël Marlu, Emmanuel de Maistre, Charles Tacquard, Jerrold H. Levy, Anne Godier, Sophie Susen, Pierre Albaladejo |
| 112 |
[GO] |
2021―Jun―16 |
When to use anticoagulation in COVID-19 |
Matthew Moll, Jean M. Connors |
| 113 |
[GO] |
2021―Jun―16 |
Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing |
Anastasios Kollias, Garyphallia Poulakou, Evangelos Dimakakos, Konstantinos G. Kyriakoulis, Konstantinos Syrigos |
| 114 |
[GO] |
2021―Jun―08 |
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study |
Dario Nieri, Tommaso Neri, Greta Barbieri, Sara Moneta, Giovanna Morelli, Desirè Mingardi, Stefano Spinelli, Lorenzo Ghiadoni, Marco Falcone, Giusy Tiseo, Francesco Menichetti, Maria Franzini, Laura Caponi, Aldo Paolicchi, Roberta Pancani, Francesco Pistelli, Laura Carrozzi, Alessandro Celi, Sabrina AgostiniO. Degl'Innocenti, Martina Biancalana, Matteo Borselli, Elia Nencini, Rachele Antognoli, Valeria Calsolaro, Fabio Monzani, Simone Paterni, Rubia Baldassarri, Pietro Bertini, Giulia Brizzi, Alessandra Della Rocca, Paolo Malacarne, Marco Monfroni, Chiara Piagnani, Nicoletta Carpenè, Massimiliano Desideri, Marco Gherardi, Massimiliano Serradori, Francesco Cinotti, Alessandro Cipriano, Naria Park, Giovanna Forotti, Alessandro Mengozzi, Stefano Masi, Francesca Ruberti, Maria Sciuto, Agostino Virdis, Fabrizio Maggi, Valentina Galfo |
| 115 |
[GO] |
2021―Mai―29 |
Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19 |
Tara M. Stanne, Annie Pedersen, Magnus Gisslén, Christina Jern |
| 116 |
[GO] |
2021―Mai―15 |
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
Walter Ageno, Erica De Candia, Licia Iacoviello, Augusto Di Castelnuovo |
| 117 |
[GO] |
2021―Mai―15 |
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination |
Jonathan Douxfils, Julien Favresse, Jean-Michel Dogné, Thomas Lecompte, Sophie Susen, Charlotte Cordonnier, Aurélien Lebreton, Robert Gosselin, Pierre Sié, Gilles Pernod, Yves Gruel, Philippe Nguyen, Caroline Vayne, François Mullier |
| 118 |
[GO] |
2021―Mai―08 |
Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region |
Karmele Arribalzaga, Inés Martínez-Alfonzo, Carola Díaz-Aizpun, Isabel Gutiérrez, Mario Rodríguez, Nerea Castro, Elia Pérez-Fernández, Diego Velasco-Rodríguez, Elvira Gómez, Begoña Fernández, Alba Vilches, Sara Martín-Herrero, Lucía Castilla, Mª. Jesús Blanco, Mª. del Mar Gutiérrez, Isabel Rivas, Cristina Pascual, Belén Rosado, Elena Sola, Rosa Vidal, Susana Asenjo, Mª. Asunción Mora, Laurentino Benito-Parra, Itziar Carmona, Karen Marín, Natalia Acedo, Natalia García, Alexis Marcheco, Carolina Guillén, Cristina Fernández, Ramón Rodríguez, Laura Pardo, Pablo Silva, Laura Moreno, Mar Meijón, Pilar Masso, Pilar Llamas-Sillero |
| 119 |
[GO] |
2021―Mai―03 |
Therapeutic anticoagulation in COVID-19 patients |
Anna Cristina Bertoldi Lemos, Douglas Alexandre dos Espírito Santo, Carlos Henrique Miranda |
| 120 |
[GO] |
2021―Mai―01 |
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis |
Nicola Mumoli, Giulia Conte, Marco Cei, Josè Vitale, Riccardo Capra, Giuseppe Rotiroti, Cesare Porta, Davide Monolo, Alessandra Colombo, Antonino Mazzone, Nils Kucher, Stavros V. Konstantinides, Francesco Dentali, Stefano Barco |
| 121 |
[GO] |
2021―Apr―21 |
PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19. |
A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, C. López Jiménez, C. Blanco Abad, J.L. Catoya Villa, L. Ortega Morán, M. Martín, A. Muñoz Martín |
| 122 |
[GO] |
2021―Apr―21 |
PO-35 Analysis of coagulation parameters in patients with COVID-19, data from Regional Center Shtip |
M. Shorova |
| 123 |
[GO] |
2021―Apr―21 |
OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital |
J. Illarramendi, J.L. Modesto, E. Salgado, S. De la Cruz, J.J. Illarramendi |
| 124 |
[GO] |
2021―Apr―21 |
PO-57 Characteristics of venous thromboembolism following COVID-19 in Croatia |
B. Barišić, S. Zupančić-Šalek, D. Županić Krmek, M. Međugorac, E. Galić, J. Faletar |
| 125 |
[GO] |
2021―Apr―21 |
OC-03 Heparin treatment in COVID-19 patients is associated with reduced in-hospital mortality: findings from an observational multicenter study in Italy and a meta-analysis of 11 studies |
S. Costanzo, R. Parisi, G. de Gaetano, M.B. Donati, L. Iacoviello, A. Di Castelnuovo |
| 126 |
[GO] |
2021―Apr―21 |
PO-56 Relationship between clinical presentation of SARS-CoV-2 infection and risk of thromboembolic events and prognosis in cancer patients |
J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, C. López Jiménez, C. Blanco Abad, L. Ortega Morán, M. Martín Jiménez, A. Muñoz Martín |
| 127 |
[GO] |
2021―Apr―21 |
OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients |
C. López Jiménez, C. Blanco Abad, J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, L. Ortega Morán, M. Martín Jiménez, A. Muñoz Martín |
| 128 |
[GO] |
2021―Apr―21 |
PO-58 Venous and arterial tromboembolic events among hospitalized cancer patients with SARS-COV2 infection |
C. Blanco Abad, J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, S. Juliao Caamaño, C. López Jiménez, L. Ortega Morán, M. Martín Jiménez, A. Muñoz Martín |
| 129 |
[GO] |
2021―Apr―20 |
COVID-19 and thrombotic microangiopathies |
Nishant R. Tiwari, Sanat Phatak, Vivek R. Sharma, Sanjay K. Agarwal |
| 130 |
[GO] |
2021―Apr―19 |
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis |
Matthew Moll, Rebecca L. Zon, Katelyn W. Sylvester, Evan C. Chen, Auyon J. Ghosh, Eric Abston, Vivien Cheng, Aaron Hakim, Nathan T. Connell, Laura E. Fredenburgh, Rebecca M. Baron, Brian D. Hobbs, Michael H. Cho, Murray A. Mittleman, Ann E. Woolley, Jean M. Connors |
| 131 |
[GO] |
2021―Apr―19 |
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients |
Paola S. Preti, Mariaconcetta Russo, Luca Caneva, Margherita Reduzzi, Francesca Calabretta, Carmine Spataro, Paolo Grimaldi, Mara De Amici, Giorgia Testa, Giorgio A. Iotti, Francesco Mojoli, Antonio Di Sabatino |
| 132 |
[GO] |
2021―Apr―19 |
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy |
Ruben Rhoades, Ron Leong, Jason Kopenitz, Brandi Thoma, Lydia McDermott, Joseph Dovidio, Shannon Barletti, Jerald Z. Gong, Howard T. Massey, Steven E. McKenzie, J. Eduardo Rame, Nawar Al-Rawas |
| 133 |
[GO] |
2021―Apr―09 |
D-dimer Driven Deep Vein Thrombosis Prophylaxis Strategy for Hospitalized Patients with COVID-19 |
Kristin Stawiarski, Ariane Loutoo, Leah Velardi, Stuart Zarich |
| 134 |
[GO] |
2021―Apr―08 |
Cerebral venous thrombosis and thrombocytopenia post- COVID-19 vaccination |
Massimo Franchini, Sophie Testa, Mario Pezzo, Claudia Glingani, Beatrice Caruso, Isabella Terenziani, Claudio Pognani, Simona Aurelia Bellometti, Gianpaolo Castelli |
| 135 |
[GO] |
2021―Apr―01 |
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic |
Daniela Husser, Sven Hohenstein, Vincent Pellissier, Sebastian König, Laura Ueberham, Gerhard Hindricks, Andreas Meier-Hellmann, Ralf Kuhlen, Andreas Bollmann |
| 136 |
[GO] |
2021―Mrz―24 |
COVID-19 in thrombosis research: An editorial perspective |
S. Barco, S.M. Bates, H.H. Versteeg, F.A. Klok |
| 137 |
[GO] |
2021―Mrz―23 |
COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism |
Inge Kirchberger, Thomas M. Berghaus, Wolfgang von Scheidt, Jakob Linseisen, Christine Meisinger |
| 138 |
[GO] |
2021―Mrz―08 |
Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study |
Suleman Aktaa, Jianhua Wu, Ramesh Nadarajah, Muhammad Rashid, Mark de Belder, John Deanfield, Mamas A. Mamas, Chris P. Gale |
| 139 |
[GO] |
2021―Mrz―07 |
The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19 |
Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Carlos Andrés Rodríguez-Toledo, Antonio Camiro Zúñiga, Roberta Demichelis |
| 140 |
[GO] |
2021―Mrz―05 |
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research |
Bernhard Lämmle, Heidi Rossmann |
| 141 |
[GO] |
2021―Feb―26 |
Three-month follow-up of Pulmonary Embolism in patients with COVID-19 |
Martin B. Whyte, Rosemary Barker, Philip A. Kelly, Elisa Gonzalez, Julia Czuprynska, Raj K. Patel, Catherine Rea, Felicity Perrin, Michael Waller, Caroline Jolley, Roopen Arya, Lara N. Roberts |
| 142 |
[GO] |
2021―Feb―24 |
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability |
T.W. van de Berg, A.M. Hulshof, Magdolna Nagy, Rene van Oerle, Jan-Willem Sels, Bas van Bussel, Hugo ten Cate, Yvonne Henskens, Henri M.H. Spronk |
| 143 |
[GO] |
2021―Feb―18 |
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19 |
Peter L. Turecek, Rachel C. Peck, Savita Rangarajan, Christopher Reilly-Stitt, Michael A. Laffan, Rashid Kazmi, Izabela James, Ahilanandan Dushianthan, Gerald Schrenk, Herbert Gritsch, Bruce M. Ewenstein, Bjorn Mellgard, Wolfhard Erdlenbruch, Nisha Jain, Nikolaus B. Binder, Andrew D. Mumford |
| 144 |
[GO] |
2021―Feb―17 |
DIC in COVID-19 |
Xianghui Zhou, Zhipeng Cheng, Lili Luo, Ying Zhu, Wenyi Lin, Zhangyin Ming, Wei Chen, Yu Hu |
| 145 |
[GO] |
2021―Feb―17 |
Therapeutic anticoagulation in COVID-19 patients |
O. Belfaqeeh, J. Patel, R.N. Janapala, A. Pourmand |
| 146 |
[GO] |
2021―Feb―09 |
Fondaparinux and bleeding risk in COVID-19: unsolved question |
Vincenzo Russo, Riccardo Proietti, Corrado Lodigiani, Pierpaolo Di Micco |
| 147 |
[GO] |
2021―Feb―09 |
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 |
Tiffany Pascreau, Sara Zia-Chahabi, Benjamin Zuber, Colas Tcherakian, Eric Farfour, Marc Vasse |
| 148 |
[GO] |
2021―Feb―02 |
Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study |
L.I. van der Wal, L.J.M. Kroft, L.F. van Dam, C.M. Cobbaert, J. Eikenboom, M.V. Huisman, H.J.F. Helmerhorst, F.A. Klok, E. de Jonge |
| 149 |
[GO] |
2021―Jan―26 |
Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: a multicenter case-control study |
Jasper M. Smit, Jorge E. Lopez Matta, Roel Vink, Marcella C.A. Müller, Kee F. Choi, Frank E.H.P. van Baarle, Alexander P.J. Vlaar, Frederikus A. Klok, Menno V. Huisman, Carlos V. Elzo Kraemer, Armand R.J. Girbes, David J. Van Westerloo, Pieter R. Tuinman |
| 150 |
[GO] |
2021―Jan―18 |
Mechanisms of thrombosis and cardiovascular complications in COVID-19 |
Eden M. Page, Robert A.S. Ariëns |
| 151 |
[GO] |
2021―Jan―07 |
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study |
Caroline Sindet-Pedersen, Jonas Bjerring Olesen, Paul Blanche, Thomas Alexander Gerds, Jarl Emanuel Strange, Jawad Haider Butt, Mohamad El-Chouli, Matthew Phelps, Morten Lock Hansen, Morten Schou, Lars Køber, Emil Fosbøl, Christian Torp-Pedersen, Gunnar H. Gislason |
| 152 |
[GO] |
2021―Jan―07 |
Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: a retrospective study |
Nuria Muñoz-Rivas, Ane Abad-Motos, Beatriz Mestre-Gómez, Fernando Sierra-Hidalgo, Cristina Cortina-Camarero, Rosa María Lorente-Ramos, Pedro Torres-Rubio, Paz Arranz-García, Ana Isabel Franco-Moreno, Eloy Gómez-Mariscal, Cristina Mauleón-Fernández, Soledad Alonso-García, Jacobo Rogado, Teresa Saez-Vaquero, Ana Such-Diaz, Pablo Ryan, Eva Moya-Mateo, Juan A. Martín-Navarro, Jose Angel Hernández-Rivas, Juan Torres-Macho, Juan Churruca |
| 153 |
[GO] |
2020―Dez―30 |
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave |
F.H.J. Kaptein, M.A.M. Stals, M. Grootenboers, S.J.E. Braken, J.L.I. Burggraaf, B.C.T. van Bussel, S.C. Cannegieter, H. ten Cate, H. Endeman, D.A.M.P.J. Gommers, C. van Guldener, E. de Jonge, N.P. Juffermans, K.M. Kant, M.E. Kevenaar, S. Koster, L.J.M. Kroft, M.J.H.A. Kruip, J. Leentjens, C. Marechal, Y.L. Soei, L. Tjepkema, C. Visser, F.A. Klok, M.V. Huisman |
| 154 |
[GO] |
2020―Dez―29 |
The effect of race on composite thrombotic events in patients with COVID-19 |
Charles Esenwa, Santiago R. Unda, David J. Altschul, Nikunj K. Patel, Avinash Malaviya, Johanna Seiden, Andrea Lendaris, Khadean Moncrieffe, Daniel L. Labovitz |
| 155 |
[GO] |
2020―Dez―29 |
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? |
Anastasios Kollias, Konstantinos G. Kyriakoulis, Nikolaos K. Syrigos, George S. Stergiou |
| 156 |
[GO] |
2020―Dez―26 |
Utility of D-Dimer in Predicting Venous Thromboembolism in Non-Mechanically Ventilated COVID-19 Survivors |
Peter C. Nauka, Sarah W. Baron, Andrei Assa, Laurel Mohrmann, Shawn Jindal, Erick Oran, Galina Glazman-Kuczaj, William N. Southern, Sweta Chekuri |
| 157 |
[GO] |
2020―Dez―11 |
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: prospective results from a multi-center study |
Farid Rashidi, Stefano Barco, Farin Kamangar, Gustavo A. Heresi, Ashkan Emadi, Cihangir Kaymaz, Pavel Jansa, Abilio Reis, Arash Rashidi, Ali Taghizadieh, Parisa Rezaeifar, Minoosh Moghimi, Samad Ghodrati, Abolfazl Mozafari, Ali Alavi Foumani, Ouria Tahamtan, Effat Rafiee, Zahra Abbaspour, Kasra Khodadadi, Golsa Alamdari, Yasman Boodaghi, Maryam Rezaei, Muhammad Javad Muhammadi, Meysam Abbasi, Fatemeh Movaseghi, Ata Koohi, Leila Shakourzad, Fatemeh Ebrahimi, Sarvin Radvar, Maryam Amoozadeh, Fatemeh Fereidooni, Hanieh Naseari, Kobra Movalled, Ozra Ghorbani, Khalil Ansarin |
| 158 |
[GO] |
2020―Dez―02 |
Association of Anticoagulation Use with SARS-CoV2 Detection |
Juraj Kavecansky, Jennifer R. Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai |
| 159 |
[GO] |
2020―Nov―28 |
Discordance In Activated Partial Thromboplastin Time and Anti-factor Xa Levels in COVID-19 Patients on Heparin Therapy |
Matthew Lawlor, Aakriti Gupta, Lauren S. Ranard, Mahesh V. Madhavan, Jianhua Li, Andrew Eisenberger, Sahil A. Parikh, Sanjum S. Sethi, Amirali Masoumi |
| 160 |
[GO] |
2020―Nov―27 |
Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management” [Thromb. Res., 194, October 2020, Pages 101-115] |
Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha Nayak |
| 161 |
[GO] |
2020―Nov―23 |
Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
Wei Qin, Fen Dong, Zhu Zhang, Bingzhu Hu, Shi Chen, Ziyang Zhu, Fajiu Li, Xiaojiang Wang, Yunxia Zhang, Yimin Wang, Kaiyuan Zhen, Jing Wang, Ismaïl Elalamy, Chenghong Li, Zhenguo Zhai, Bruce L. Davidson, Chen Wang |
| 162 |
[GO] |
2020―Nov―17 |
Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome |
Fernando Scudiero, Angelo Silverio, Marco Di Maio, Vincenzo Russo, Rodolfo Citro, Davide Personeni, Andrea Cafro, Antonello D'Andrea, Emilio Attena, Salvatore Pezzullo, Mario Enrico Canonico, Gennaro Galasso, Antonino Pitì, Guido Parodi |
| 163 |
[GO] |
2020―Nov―11 |
In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis |
Amit K.J. Mandal, Jason Kho, Adam Ioannou, Koenraad Van den Abbeele, Constantinos G. Missouris |
| 164 |
[GO] |
2020―Nov―07 |
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study |
Benjamin Planquette, Alice Le Berre, Lina Khider, Alexandra Yannoutsos, Nicolas Gendron, Marie de Torcy, Nassim Mohamedi, Stéphane Jouveshomme, David M. Smadja, Isabelle Lazareth, Guillaume Goudot, Laure Fournier, Cédric Bruel, Jean Luc Diehl, Jean-Jacques Mourad, Guy Meyer, Pascal Priollet, Emmanuel Messas, Olivier Sanchez, Hélène Beaussier, Tristan Mirault, Marc Zins, Gilles Chatelier, Joseph Emmerich |
| 165 |
[GO] |
2020―Nov―07 |
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic |
Rachna Patel, Julia Czuprynska, Lara N. Roberts, Bipin Vadher, Catherine Rea, Raj Patel, Emma Gee, Gabrielle Saul, Evelyn Coles, Alison Brown, Rosalind Byrne, Vicky Speed, Jignesh P. Patel, Roopen Arya |
| 166 |
[GO] |
2020―Nov―06 |
Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units |
Roberta Pancani, Liliana Villari, Valentina Foci, Giulia Parri, Francesco Barsotti, Filippo Patrucco, Mario Malerba, Rigoletta Vincenti, Laura Carrozzi, Alessandro Celi |
| 167 |
[GO] |
2020―Nov―06 |
Major cardiovascular events in patients with Coronavirus Disease 2019: experience of a cardiovascular Department of Northern Italy |
Raffaello Bellosta, Matteo Alberto Pegorer, Luca Bettari, Luca Luzzani, Luca Attisani, Alessandro Fossati, Letizia Consoli, Diego Maffeo, Claudio Cuccia, Paolo Terragnoli, Ruth L. Bush, Gabriele Piffaretti |
| 168 |
[GO] |
2020―Nov―05 |
The effect of anticoagulation on clinical outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort |
Lei Lynn, Juan A. Reyes, Katrina Hawkins, Arjun Panda, Laura Linville, Walaa Aldhahri, Ghazal Kango, Sneha Shah, Shant Ayanian, Karolyn Teufel |
| 169 |
[GO] |
2020―Okt―24 |
Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study |
Michaël Hardy, Isabelle Michaux, Sarah Lessire, Jonathan Douxfils, Jean-Michel Dogné, Marion Bareille, Geoffrey Horlait, Pierre Bulpa, Celine Chapelle, Silvy Laporte, Sophie Testa, Hugues Jacqmin, Thomas Lecompte, Alain Dive, François Mullier |
| 170 |
[GO] |
2020―Okt―23 |
In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist |
Lan Wang, Fei Chen, Lang Bai, Qun Yi, Yong Peng |
| 171 |
[GO] |
2020―Okt―15 |
The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison |
Renée R.A.G. Brüggemann, Bart Spaetgens, Hester A. Gietema, Steffie H.A. Brouns, Patricia M. Stassen, Fabienne J. Magdelijns, Roger J. Rennenberg, Ronald M.A. Henry, Mark M.G. Mulder, Bas C.T. van Bussel, Ronny M. Schnabel, Iwan C.C. van der Horst, Joachim E. Wildberger, Coen D.A. Stehouwer, Hugo ten Cate |
| 172 |
[GO] |
2020―Okt―15 |
COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose Thromboprophylaxis strategy |
Molly M. Daughety, Andrew Morgan, Erin Frost, Chester Kao, Joyce Hwang, Rachel Tobin, Bhavik Patel, Matthew Fuller, Ian Welsby, Thomas L. Ortel |
| 173 |
[GO] |
2020―Okt―15 |
Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection |
Alex Bourguignon, Camille Beaulieu, Wiam Belkaid, Antoine Desilets, Normand Blais |
| 174 |
[GO] |
2020―Okt―12 |
D-dimer measurement in COVID-19: Silver bullet or clinical distraction? |
Giuseppe Lippi, Emmanuel J. Favaloro |
| 175 |
[GO] |
2020―Okt―09 |
More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism |
L.F. van Dam, L.J.M Kroft, L.I. van der Wal, S.C. Cannegieter, J. Eikenboom, E. de Jonge, M.V. Huisman, F.A. Klok |
| 176 |
[GO] |
2020―Okt―08 |
Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units |
Andrew J. Doyle, Will Thomas, Andrew Retter, Martin Besser, Stephen MacDonald, Karen A. Breen, Michael J.R. Desborough, Beverley J. Hunt |
| 177 |
[GO] |
2020―Okt―08 |
Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence |
Behnood Bikdeli |
| 178 |
[GO] |
2020―Okt―08 |
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
Mattia Trunfio, Elena Salvador, Daniela Cabodi, Letizia Marinaro, Chiara Alcantarini, Alberto Gaviraghi, Alice Trentalange, Filippo Lipani, Savino Sciascia, Dario Roccatello, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno |
| 179 |
[GO] |
2020―Sep―24 |
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies |
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, Hashem Sezavar, Ali Dabbagh, Mohammad Taghi Beigmohammadi, Pooya Payandemehr, Mahdi Yadollahzadeh, Taghi Riahi, Hossein Khalili, Sepehr Jamalkhani, Parisa Rezaeifar, Atefeh Abedini, Somayeh Lookzadeh, Shaghayegh Shahmirzaei, Ouria Tahamtan, Samira Matin, Ahmad Amin, Seyed Ehsan Parhizgar, David Jimenez, Aakriti Gupta, Mahesh V. Madhavan, Sahil A. Parikh, Manuel Monreal, Naser Hadavand, Alireza Hajighasemi, Majid Maleki, Saeed Sadeghian, Bahram Mohebbi, Gregory Piazza, Ajay J. Kirtane, Gregory Y.H. Lip, Harlan M. Krumholz, Samuel Z. Goldhaber, Parham Sadeghipour |
| 180 |
[GO] |
2020―Sep―23 |
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia |
Andrew Hsu, Yuchen Liu, Adam S. Zayac, Adam J. Olszewski, John L. Reagan |
| 181 |
[GO] |
2020―Sep―21 |
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID) |
Anna Cristina Bertoldi Lemos, Douglas Alexandre do Espírito Santo, Maísa Cabetti Salvetti, Renato Noffs Gilio, Lucas Barbosa Agra, Antonio Pazin-Filho, Carlos Henrique Miranda |
| 182 |
[GO] |
2020―Sep―17 |
D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19 |
Justin J. Choi, Graham T. Wehmeyer, Han A. Li, Mark N. Alshak, Musarrat Nahid, Mangala Rajan, Bethina Liu, Emma M. Schatoff, Rahmi Elahjji, Youmna Abdelghany, Debra D'Angelo, Daniel Crossman, Arthur T. Evans, Peter Steel, Laura C. Pinheiro, Parag Goyal, Monika M. Safford, Gregory Mints, Maria T. DeSancho |
| 183 |
[GO] |
2020―Sep―17 |
The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin |
Paolo Prandoni, Anna Maria Cattelan, Laura Carrozzi, Lucia Leone, Lucia Filippi, Egidio De Gaudenzi, Sabina Villalta, Raffaele Pesavento |
| 184 |
[GO] |
2020―Sep―16 |
COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic |
Anna L. Parks, Andrew D. Auerbach, Jeffrey L. Schnipper, James E. Anstey, David G. Sterken, Todd E.H. Hecht, Margaret C. Fang, Valerie M. Vaughn, Andrew S. Dunn, Anne S. Linker, Daniel P. Hunt, Justin J. Choi, Daniel J. Brotman, Michael B. Streiff, Melissa L.P. Mattison, Matthew A. Pappas, S. Ryan Greysen, David F. Hemsey, Kwame Dapaah-Afriyie, Neera Ahuja, William J. Collins, Shoshana J. Herzig, Sanjay Bhandari, Eric R. Schumacher, Vijay S. Duggirala, Kevin J. O'Leary, Geraldine E. Menard, Michael Y. Lin |
| 185 |
[GO] |
2020―Sep―15 |
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients |
Romein W.G. Dujardin, Bashar N. Hilderink, Wolmet E. Haksteen, S. Middeldorp, Alexander P.J. Vlaar, J. Thachil, Marcella C.A. Müller, Nicole P. Juffermans |
| 186 |
[GO] |
2020―Sep―13 |
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation |
Domenico Paparella, Mario Colucci, Enrico Squiccimarro, Pasquale Raimondo, Federica De Palma, Prudenza Ranieri, Maria Addolorata Mariggiò, Salvatore Grasso |
| 187 |
[GO] |
2020―Sep―13 |
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action |
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri |
| 188 |
[GO] |
2020―Sep―10 |
Association between Covid-19 and Pulmonary Embolism (AC-19-PE study) |
Òscar Miró, Pere Llorens, Alfons Aguirre, Laura Lozano, Sebastien Beaune, Mélanie Roussel, Pierrick Le Borgne, Tahar Chouihed, Yonathan Freund |
| 189 |
[GO] |
2020―Sep―07 |
Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease |
Jan A. Ruzicka |
| 190 |
[GO] |
2020―Sep―03 |
Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency |
Roberto Pizzi, Giancarlo Gini, Lucia Caiano, Beniamino Castelli, Noga Dotan, Federica Magni, Alexandra Virano, Andrea Roveda, Lorenza Berté, Walter Ageno |
| 191 |
[GO] |
2020―Sep―01 |
Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization |
Rajkumar Rajendram, Ghulam Abbas Kharal, Naveed Mahmood, Mubashar Kharal |
| 192 |
[GO] |
2020―Sep―01 |
Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients |
Nadine van Veenendaal, Thomas W.L. Scheeren, Karina Meijer, Peter H.J. van der Voort |
| 193 |
[GO] |
2020―Sep―01 |
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity |
Adriana Torres-Machorro, Victor Manuel Anguiano-Álvarez, Flavio Adrian Grimaldo-Gómez, Hugo Rodríguez-Zanella, Evelyn Cortina de la Rosa, Sergio Mora-Canela, Claudia Lerma, Edgar García-Cruz, Ángel Ramos-Enriquez, Samuel Ramirez-Marroquin, Raúl Izaguirre-Ávila, Gustavo Rojas-Velasco |
| 194 |
[GO] |
2020―Aug―27 |
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? |
Serena Del Turco, Annamaria Vianello, Rosetta Ragusa, Chiara Caselli, Giuseppina Basta |
| 195 |
[GO] |
2020―Aug―25 |
Role of upfront CT pulmonary angiography at admission in COVID-19 patients |
Carole Jalaber, Marie-Pierre Revel, Guillaume Chassagnon, Emma Bajeux, Thibaut Lapotre, Pierre Croisille, Mathieu Lederlin |
| 196 |
[GO] |
2020―Aug―24 |
Anticoagulation and bleeding risk in patients with COVID-19 |
Nancy Musoke, Kevin Bryan Lo, Jeri Albano, Eric Peterson, Ruchika Bhargav, Fahad Gul, Robert DeJoy, Grace Salacup, Jerald Pelayo, Padmavathi Tipparaju, Zurab Azmaiparashvili, Gabriel Patarroyo-Aponte, Janani Rangaswami |
| 197 |
[GO] |
2020―Aug―22 |
Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia |
L.F.M. Beenen, L.D. Bos, M.J. Scheerder, N.H.J. Lobé, M.C.A. Muller, M.J. Schultz, J.G. van den Aardweg, A. Goorhuis, P.I. Bonta, S. Middeldorp, A.P. Vlaar |
| 198 |
[GO] |
2020―Aug―21 |
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19 |
Maxime G. Zermatten, Olivier Pantet, Francisco Gomez, Antoine Schneider, Marie Méan, Lucia Mazzolai, Olivier Hugli, Pierre-Alexandre Bart, Matthaios Papadimitriou-Olivgeris, Lorenzo Alberio |
| 199 |
[GO] |
2020―Aug―21 |
Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients |
D.J. Hoechter, A. Becker-Pennrich, J. Langrehr, M. Bruegel, B. Zwissler, S. Schaefer, M. Spannagl, L.C. Hinske, M. Zoller |
| 200 |
[GO] |
2020―Aug―20 |
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 |
Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin, Sirish Dharmapuri, Tomi Jun, Sheena Bhalla, Shana Berwick, Krina Christian, John Mascarenhas, Francine Dembitzer, Erin Moshier, Douglas Tremblay |
| 201 |
[GO] |
2020―Aug―19 |
Managing suspected venous thromboembolism when a pandemic limits diagnostic testing |
Jordan K. Schaefer, Peter K. Henke, Geoffrey D. Barnes |
| 202 |
[GO] |
2020―Aug―12 |
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis |
Angelo Porfidia, Emanuele Valeriani, Roberto Pola, Ettore Porreca, Anne W.S. Rutjes, Marcello Di Nisio |
| 203 |
[GO] |
2020―Aug―11 |
Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis |
Setor K. Kunutsor, Jari A. Laukkanen |
| 204 |
[GO] |
2020―Aug―10 |
COVID-19 versus HIT hypercoagulability |
Theodore E. Warkentin, Scott Kaatz |
| 205 |
[GO] |
2020―Aug―09 |
Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
W. Thomas, D. White, S. Cox-Morton, S. MacDonald, M. Besser |
| 206 |
[GO] |
2020―Aug―06 |
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg |
Francesca Pizzolo, Anna Maria Rigoni, Sergio De Marchi, Simonetta Friso, Elisa Tinazzi, Giulia Sartori, Filippo Stefanoni, Francesca Nalin, Martina Montagnana, Sara Pilotto, Michele Milella, Anna Maria Azzini, Evelina Tacconelli, Giacomo Marchi, Domenico Girelli, Oliviero Olivieri, Nicola Martinelli |
| 207 |
[GO] |
2020―Aug―04 |
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19 |
Ching-Tai Huang, Shao-Yun Hsu, Ko-Wei Chang, Chung-Guei Huang, Cheng-Ta Yang, Ming-Huei Cheng |
| 208 |
[GO] |
2020―Aug―04 |
Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients |
Vasiliki Tsolaki, George E. Zakynthinos, Konstantinos Mantzarlis |
| 209 |
[GO] |
2020―Aug―03 |
The reversed halo sign: Considerations in the context of the COVID-19 pandemic |
Edson Marchiori, Luiz Felipe Nobre, Bruno Hochhegger, Gláucia Zanetti |
| 210 |
[GO] |
2020―Jul―31 |
Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark |
Peter Vibe Rasmussen, Paul Blanche, Jarl Emanuel Strange, Jawad Haider Butt, Frederik Dalgaard, Kristian Kragholm, Matthew Phelps, Gunnar Gislason, Morten Lock Hansen |
| 211 |
[GO] |
2020―Jul―27 |
D-dimer level is associated with the severity of COVID-19 |
Hai-Han Yu, Chuan Qin, Man Chen, Wei Wang, Dai-Shi Tian |
| 212 |
[GO] |
2020―Jul―22 |
Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study |
Björn Stessel, Charlotte Vanvuchelen, Liesbeth Bruckers, Laurien Geebelen, Ina Callebaut, Jeroen Vandenbrande, Ben Pellens, Michiel van Tornout, Jean-Paul Ory, Karlijn van Halem, Peter Messiaen, Lieven Herbots, Dirk Ramaekers, Jasperina Dubois |
| 213 |
[GO] |
2020―Jul―17 |
Venous thromboembolism in non-critically ill patients with COVID-19 infection |
Antonin Trimaille, Anaïs Curtiaud, Benjamin Marchandot, Kensuke Matsushita, Chisato Sato, Ian Leonard-Lorant, Laurent Sattler, Lelia Grunebaum, Mickaël Ohana, Jean-Jacques Von Hunolstein, Emmanuel Andres, Bernard Goichot, François Danion, Charlotte Kaeuffer, Vincent Poindron, Patrick Ohlmann, Laurence Jesel, Olivier Morel |
| 214 |
[GO] |
2020―Jul―10 |
Pulmonary embolism in hospitalised patients with COVID-19 |
Martin B. Whyte, Philip A. Kelly, Elisa Gonzalez, Roopen Arya, Lara N. Roberts |
| 215 |
[GO] |
2020―Jul―09 |
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study |
Ying-yi Luan, Yan Liu, Xue-yan Liu, Bao-jun Yu, Rong-ling Chen, Mian Peng, Di Ren, Hao-li Li, Lei Huang, Yong Liu, Jin-xiu Li, Yong-wen Feng, Ming Wu |
| 216 |
[GO] |
2020―Jul―09 |
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019 |
Stephanie Hightower, Harvey Ellis, Jacob Collen, John Ellis, Ian Grasso, Joseph Roswarski, Andrew P. Cap, Kevin Chung, Lindsey Prescher, Michael Kavanaugh, Tara Brown, Mark Nau, Paul Clark |
| 217 |
[GO] |
2020―Jul―08 |
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? |
Virginie Siguret, Sebastian Voicu, Marie Neuwirth, Maxime Delrue, Etienne Gayat, Alain Stépanian, Bruno Mégarbane |
| 218 |
[GO] |
2020―Jul―05 |
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case |
Fehmi Hindilerden, Ipek Yonal-Hindilerden, Emre Akar, Kadriye Kart-Yasar |
| 219 |
[GO] |
2020―Jun―27 |
Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation |
Arshed Hussain Parry, Abdul Haseeb Wani, Mudasira Yaseen, Mohd Iqbal Dar |
| 220 |
[GO] |
2020―Jun―27 |
The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
Giulia Previtali, Michela Seghezzi, Valentina Moioli, Aurelio Sonzogni, Lorenzo Cerutti, Roberto Marozzi, Rudi Ravasio, Andrea Gianatti, Giovanni Guerra, Maria Grazia Alessio |
| 221 |
[GO] |
2020―Jun―26 |
Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship |
Vittorio Pavoni, Lara Gianesello |
| 222 |
[GO] |
2020―Jun―20 |
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management |
Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha Nayak |
| 223 |
[GO] |
2020―Jun―19 |
Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases |
Siri Overstad, Eirik Tjonnfjord, Lamya Garabet, Synne Fronas, Jonas Bergan, Saad Aballi, Waleed Ghanima |
| 224 |
[GO] |
2020―Jun―18 |
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review |
Alexander Fletcher-Sandersjöö, Bo-Michael Bellander |
| 225 |
[GO] |
2020―Jun―18 |
A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients |
E.H. Adam, K. Zacharowski, W. Miesbach |
| 226 |
[GO] |
2020―Jun―13 |
Portal vein thrombosis in a patient with COVID-19 |
A. Franco-Moreno, E. Piniella-Ruiz, J. Montoya-Adarraga, C. Ballano-Franco, F. Alvarez-Miguel, C. Peinado-Martinez, E. Landete-Hernandez, T. Saez-Vaquero, M. Ulla-Anes, J. Torres-Macho |
| 227 |
[GO] |
2020―Jun―09 |
Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient |
Marta Guillan, Javier Villacieros-Alvarez, Sara Bellido, Concepcion Perez-Jorge Peremarch, Victor M. Suarez-Vega, Maria Aragones-Garcia, Celina Cabrera-Rojo, Jose Fernandez-Ferro |
| 228 |
[GO] |
2020―Jun―08 |
COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism? |
Maurizio Gabrielli, Priscilla Lamendola, Alessandra Esperide, Federico Valletta, Francesco Franceschi |
| 229 |
[GO] |
2020―Jun―06 |
Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? |
L.F. van Dam, L.J.M. Kroft, L.I. van der Wal, S.C. Cannegieter, J. Eikenboom, E. de Jonge, M.V. Huisman, F.A. Klok |
| 230 |
[GO] |
2020―Jun―05 |
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19 |
Yujiao Zhang, Yingying Jiao, Zongpeng Li, Mo Yang, Jieyu Ye |
| 231 |
[GO] |
2020―Mai―30 |
A case of COVID-19 pneumonia with cerebral hemorrhage |
Jingwen Li, Xi Long, Chunli Zhu, Shaoping Hu, Zhicheng Lin, Jinghong Li, Nian Xiong |
| 232 |
[GO] |
2020―Mai―29 |
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom |
Michael J.R. Desborough, Andrew J. Doyle, Alexandra Griffiths, Andrew Retter, Karen A. Breen, Beverley J. Hunt |
| 233 |
[GO] |
2020―Mai―27 |
Thrombosis risk associated with COVID-19 infection. A scoping review |
Fatimah Al-Ani, Samer Chehade, Alejandro Lazo-Langner |
| 234 |
[GO] |
2020―Mai―23 |
COVID-19 and hypercoagulability in the outpatient setting |
Roger Emert, Payal Shah, John G. Zampella |
| 235 |
[GO] |
2020―Mai―23 |
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients |
R. Escher, N. Breakey, B. Lämmle |
| 236 |
[GO] |
2020―Mai―16 |
Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management |
Arshed Hussain Parry, Abdul Haseeb Wani |
| 237 |
[GO] |
2020―Mai―16 |
The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies |
Sajida Kazi, A. Kinga Malinowski, Maha Othman |
| 238 |
[GO] |
2020―Mai―16 |
Severe arterial thrombosis associated with Covid-19 infection |
Mahine Kashi, Aurélien Jacquin, Bassel Dakhil, Rym Zaimi, Emmanuel Mahé, Emilie Tella, Patrick Bagan |
| 239 |
[GO] |
2020―Mai―16 |
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic |
V. Speed, R.K. Patel, R. Byrne, L.N. Roberts, R. Arya |
| 240 |
[GO] |
2020―Mai―15 |
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism |
F. Galeano-Valle, C.M. Oblitas, M.M. Ferreiro-Mazón, J. Alonso-Muñoz, J. del Toro-Cervera, P. Demelo-Rodríguez |
| 241 |
[GO] |
2020―Mai―14 |
Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection |
Peter C. Nauka, Erick Oran, Sweta Chekuri |
| 242 |
[GO] |
2020―Mai―13 |
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels |
P. Demelo-Rodríguez, E. Cervilla-Muñoz, L. Ordieres-Ortega, A. Parra-Virto, M. Toledano-Macías, N. Toledo-Samaniego, A. García-García, I. García-Fernández-Bravo, Z. Ji, J. de-Miguel-Diez, L.A. Álvarez-Sala-Walther, J. del-Toro-Cervera, F. Galeano-Valle |
| 243 |
[GO] |
2020―Mai―08 |
Catheter-directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines |
S.D. Qanadli, L. Gudmundsson, D.C. Rotzinger |
| 244 |
[GO] |
2020―Mai―06 |
Early thromboembolic events in hospitalized COVID-19 patients |
Raphael J. Rosen |
| 245 |
[GO] |
2020―Mai―06 |
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China |
Jianhong Fu, Jindan Kong, Wei Wang, Meiying Wu, Lin Yao, Zhaoyue Wang, Jun Jin, Depei Wu, Xin Yu |
| 246 |
[GO] |
2020―Mai―05 |
Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection |
Claudio Vitali, Antonina Minniti, Nicoletta Del Papa |
| 247 |
[GO] |
2020―Mai―05 |
Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
U. Zachariah, S.C. Nair, A. Goel, K.A. Balasubramanian, I. Mackie, E. Elias, C.E. Eapen |
| 248 |
[GO] |
2020―Mai―01 |
COVID-19 associated pulmonary thrombosis |
C. van Nieuwkoop |
| 249 |
[GO] |
2020―Mai―01 |
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report |
Renée Brüggemann, Hester Gietema, Borefore Jallah, Hugo ten Cate, Coen Stehouwer, Bart Spaetgens |
| 250 |
[GO] |
2020―Apr―30 |
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis |
F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, D. Gommers, K.M. Kant, F.H.J. Kaptein, J. van Paassen, M.A.M. Stals, M.V. Huisman, H. Endeman |
| 251 |
[GO] |
2020―Apr―27 |
The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research? |
Chiara Mozzini, Domenico Girelli |
| 252 |
[GO] |
2020―Apr―25 |
Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom |
W. Thomas, J. Varley, A. Johnston, E. Symington, M. Robinson, K. Sheares, A. Lavinio, M. Besser |
| 253 |
[GO] |
2020―Apr―23 |
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy |
Corrado Lodigiani, Giacomo Iapichino, Luca Carenzo, Maurizio Cecconi, Paola Ferrazzi, Tim Sebastian, Nils Kucher, Jan-Dirk Studt, Clara Sacco, Bertuzzi Alexia, Maria Teresa Sandri, Stefano Barco |
| 254 |
[GO] |
2020―Apr―21 |
Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients |
Loris Roncon, Marco Zuin, Pietro Zonzin |
| 255 |
[GO] |
2020―Apr―20 |
Pulmonary embolism in a young pregnant woman with Covid-19 |
Ida Martinelli, Enrico Ferrazzi, Alessandro Ciavarella, Roberta Erra, Enrico Iurlaro, Manuela Ossola, Andrea Lombardi, Francesco Blasi, Fabio Mosca, Flora Peyvandi |
| 256 |
[GO] |
2020―Apr―20 |
Where do we stand with antithrombotic prophylaxis in patients with COVID-19? |
Alessandro Ciavarella, Flora Peyvandi, Ida Martinelli |
| 257 |
[GO] |
2020―Apr―15 |
Severe COVID-19 infection associated with endothelial activation |
Robert Escher, Neal Breakey, Bernhard Lämmle |
| 258 |
[GO] |
2020―Apr―11 |
Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography |
D.C. Rotzinger, C. Beigelman-Aubry, C. von Garnier, S.D. Qanadli |
| 259 |
[GO] |
2020―Apr―10 |
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |
F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, D.A.M.P.J. Gommers, K.M. Kant, F.H.J. Kaptein, J. van Paassen, M.A.M. Stals, M.V. Huisman, H. Endeman |
|
